(Q44371248)

2 December 2017

title

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone (English)

1 reference

2 December 2017

0 references

0 references

Bruce J Kinon

1

1 reference

2 December 2017

Julie A Gilmore

series ordinal

2

1 reference

2 December 2017

Hong Liu

series ordinal

3

1 reference

2 December 2017

Uriel M Halbreich

series ordinal

4

1 reference

2 December 2017

publication date

1 April 2003

1 reference

2 December 2017

published in

Psychoneuroendocrinology

1 reference

2 December 2017

volume

28 Suppl 2

1 reference

2 December 2017

page(s)

55-68

1 reference

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Asymptomatic hyperprolactinemia resulting from macroprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Effects of chronic hyperprolactinemia on sexual arousal and erectile function in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Decreased bone mineral density in medicated psychiatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Are chronic psychiatric patients at increased risk for developing breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Minimizing the non-extrapyramidal side-effects of antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Decreased bone density in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Effect of clozapine on human serum prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Effects of growth hormone and prolactin immune development and function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Stimulation of Intestinal Calcium Transport and Bone Calcium Mobilization by Prolactin in Vitamin D-Deficient Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Prolactin and antipsychotic medications: mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Relations between psychotic symptoms and serum prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Bone density in amenorrheic women with and without hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Prolactin: a stimulator of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Galactorrhea: subjective response by schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900127-0

7 January 2021

10.1016/S0306-4530(02)00127-0

Identifiers

DOI

1 reference

release_rapgteh6uzfqdkle4z6p2envum

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rapgteh6uzfqdkle4z6p2envum

24 November 2022

mapped directly with Wikidata item

1 reference